|
Session 120
Poster Abstracts
Resistance Assays and Their Interpretation
Tuesday, 1-2:30 pm
Poster Hall |
| 686 |
A Single-cycle and Multiple-cycle Replication Capacity Assay Gives Discordant Results for Some HIV-1 Drug-resistant Mutants
Carrie Dykes* and L Demeter
Univ of Rochester Sch of Med and Dentistry, NY, US |
| 687 |
Defining the Upper and Lower Clinical Cutoffs for Etravirine in the PhenoSense HIV Assay
Eoin Coakley*1, C Chappey2, J Benhamida2, L Napolitano2, L Tambuyzer1, J Vingerhoets1, M De Bethune1, and G Picchio3
1Tibotec BVBA, Mechelen, Belgium; 2Monogram Biosci, South San Francisco, CA, US; and 3Tibotec, Yardley, PA, US |
688
 |
External Quality Assurance for HIV Drug Resistance Genotyping Laboratories in the WHO ResNet during 2007 to 2008
S Bertagnolio1, J Fitzgibbon2, J Bremer3, and Neil Parkin*1
1WHO, Geneva, Switzerland; 2NIAID, NIH, Bethesda, MD, US; and 3Rush Univ, Chicago, IL, US |
689
|
The WHO Updated List of Mutations for Surveillance of Transmitted Drug-resistant HIV
Diane Bennett*1, D Pillay2, V Miller3, R Kantor4, J Schapiro5, D Van Der Vijver6, A-M Vandamme7, R Camacho8, M Jordan9, R Shafer5, and WHO Surveillance Mutations List Working Group
1WHO, Geneva, Switzerland; 2Ctr for Virology, Univ Coll London, UK; 3Forum for Collaborative HIV Res, George Washington Univ, Washington, DC, US; 4Brown Univ, Providence, RI, US; 5Stanford Univ, CA, US; 6Erasmus Med Ctr, Rotterdam, The Netherlands; 7Rega Inst for Med Res, Leuven, Belgium; 8Inst of Hygiene and Tropical Med, Lisbon, Portugal; and 9New England Med Ctr, Boston, MA, US |
|
